| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.0075 | 1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.0093 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0036 | 1 |